Griepke, S, Grentzmann, A, Tripodi, GL, Hansen, J, da Fonseca, MP, Nilsson, MD, Tallouzi, Y, Grupe, E, Jensen, PS, Beck, HC, Temprano-Sagrera, G, Sabater-Lleal, M, Burton, M, Dembic, M, Thomassen, M, Forteza, MJ, Terp, MG, Lindholt, JS, Rasmussen, LM, Steffensen, LB, Stubbe, J, Ketelhuth, DFJ. Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation. CARDIOVASCULAR RESEARCH. 2025; 121(8)DOI:10.1093/cvr/cvaf032. PMID:40037693. IF:13.300(Q1/1D).

de Dios, A, Pagès-Puigdemont, N, Ojeda, S, Riera, P, Pelegrin, R, Morollon, N, Belvís, R, Real, J, Masip, M. Response to the Letter to the Editor regarding "Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine". HEADACHE. 2025; 65(7)DOI:10.1111/head.14983. PMID:40668957. IF:4.000(Q1/2D).

García-González, P, Lara, HR, Compta, Y, Fernandez, M, van der Lee, SJ, de Rojas, I, Saiz, L, Painous, C, Camara, A, Muñoz, E, Marti, MJ, Valldeoriola, F, Puerta, R, Illán-Gala, I, Pagonabarraga, J, Dols-Icardo, O, Kulisevsky, J, Fortea, J, Lleó, A, Olivé, C, de Boer, SCM, Hulsman, M, Pijnenburg, YAL, Belloso, RD, Muñoz-Delgado, L, Rueda, DB, Gómez-Garre, P, Aldecoa, I, Aragonés, G, Vara, JH, Mendioroz, M, Pérez-Tur, J, Visser, PJ, den Braber, A, Papma, JM, Montes, AM, Rodriguez-Rodriguez, E, Blázquez-Folch, J, Miguel, A, García-Gutiérrez, F, Cano, A, Valero, S, Marquié, M, Capdevila-Bayo, M, Rosende-Roca, M, Quintela, I, Carracedo, A, Tàrraga, L, Real, LM, Royo, JL, Erro, ME, Guerrero, C, Torres, DC, Blázquez-Estrada, M, San Millán, B, Teijeira, S, Rolan, DV, Hernández, I, Sánchez-Soblechero, A, de la Casa-Fages, B, López, SS, Baviera-Muñoz, R, Lavín, A, Taipa, R, Amer, G, Martinez-Saez, E, Fernández-Matarrubia, M, Lage-Martínez, C, Alvarez, V, Molina-Porcel, L, Holstege, H, Mir, P, Belbin, O, Boada, M, Fernández, V, Bullido, MJ, Rábano, A, Sánchez-Juan, P, Ruiz, A. A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC. EUROPEAN JOURNAL OF HUMAN GENETICS. 2025; 33(7)DOI:10.1038/s41431-025-01872-3. PMID:40379966. IF:4.600(Q1/2D).

Prat, MS, Cuevas, AL, Ribas, IB, Fanegas, EP, Pujol, JA. Development and validation of a risk score to predict community-acquired pneumonia occurrence in the adult population. Respiratory Investigation. 2025; 63(4)DOI:10.1016/j.resinv.2025.04.012. PMID:40288222. IF:(Q/D).

Agache, I, Salazar, J, Rodriguez-Tanta, Y, Saenz, FKF, Haahtela, T, Traidl-Hoffmann, C, Damialis, A, Vecillas, L, Giovannini, M, Nadeau, KC, Pali-Schöll, I, Palomares, O, Renz, H, Schwarze, J, Pinto, BS, Urrutia-Pereira, M, Venter, C, Vercelli, D, Winders, T, Sola-Arnau, I, Alonso-Coello, P, Canelo-Aybar, C, Jutel, M, Akdis, CA. The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and Asthma. ALLERGY. 2025; 80(7)DOI:10.1111/all.16611. PMID:40495394. IF:12.000(Q1/1D).

Marcucci, M, Chan, MTV, Painter, TW, Efremov, S, Aguado, HJ, Astrakov, SV, Kleinlugtenbelt, YV, Patel, A, Cata, JP, Amir, M, Kirov, M, Leslie, K, Duceppe, E, Borges, FK, de Nadal, M, Tandon, V, Landoni, G, Likhvantsev, VV, Lomivorotov, V, Sessler, DI, Martínez-Zapata, MJ, Xavier, D, Fleischmann, E, Wang, CY, Meyhoff, CS, Wittmann, M, Torres, D, Highton, D, Jacka, M, Vishwanath, B, Zarnke, K, Sidhu, RS, Oriani, G, Ayad, S, Minear, S, Weaver, TE, Ruetzler, K, Brusasco, C, Parlow, JL, Maxwell, E, Miller, S, Mrkobrada, M, Bhatt, KSC, Rahate, P, Kowark, A, De Blasio, G, Ofori, SN, Conen, D, Srinathan, S, Szczeklik, W, Jayaram, R, Ellerkmann, RK, Momeni, M, Copland, I, Vincent, J, Balasubramanian, K, Li, ZR, Wang, MK, Li, DY, McGillion, MH, Kurz, A, Sharma, M, Short, TG, Devereaux, PJ. Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery. ANNALS OF INTERNAL MEDICINE. 2025; 178(7)DOI:10.7326/ANNALS-24-02841. PMID:40456161. IF:15.200(Q1/1D).

Ceravalls, J, Giménez-Arnau, AM, Exposito-Serrano, V, Chico, NF, Moya, AL, Bielsa, I, Ribó, P, Mascaró-Hereza, B, Bonfill-Orti, M, Spertino, J, Serra, E, Baliu-Piqué, C, Melé-Ninot, G. Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study. Actas Dermo-Sifiliograficas. 2025; 116(7)DOI:10.1016/j.ad.2024.08.014. PMID:. IF:(Q/D).

Selma-Gonzalez J, Rubio-Guerra S, García-Castro J, Vera-Campuzano E, Sala I, Sánchez-Saudinós MB, Zhu N, Arranz J, Arriola-Infante JE, Rodríguez-Baz Í, Maure-Blesa L, Dols-Icardo O, Videla L, Valldeneu S, Barroeta I, Santos-Santos M, Carmona-Iragui M, Vaqué-Alcázar L, Alvarez-Sanchez E, Lorente O, Carreras M, Belbin O, Arslan B, Ashton NJ, Zetterberg H, Blennow K, Montoliu-Gaya L, Bejanin A, Lleó A, Fortea J, Alcolea D, Illan-Gala I. Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages.. NEUROLOGY. 2025; 105(1)DOI:10.1212/WNL.0000000000213769. PMID:40472304. IF:(Q/D).

Ayoub, M, Mozid, A, Philip, L, Millan, X, Khatri, J, Ungureanu, C, Bennett, J, Ghafari, C, Avran, A. Use of ReCross to Increase Success Rate With Antegrade CTO PCI-A Multicenter Observational Study. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2025; 106(1)DOI:10.1002/ccd.31585. PMID:40384369. IF:2.100(Q3/6D).

Kerneis, M, Ammirati, E, Delmas, C, Heggermont, W, Heymans, S, Lenz, M, Madonna, R, Morosin, M, Schaubroeck, H, Sionis, A, Tsaban, G, Uzokov, J, Vardanyan, K, Vandenbriele, C, Roubille, F. Clinical management of acute myocarditis in daily practice: an expert practical view. European Heart Journal-Acute Cardiovascular Care. 2025; 14(7)DOI:10.1093/ehjacc/zuaf057. PMID:40198815. IF:4.600(Q1/2D).

Rodríguez-Goncer, I, Ruiz-Arabi, E, Herrera, S, Sabé, N, Los-Arcos, I, Silva, JT, Perez-Nadales, E, Machuca, I, Alvarez, R, Valerio, M, Castón, JJ, Aguilera, V, Bodro, M, Cano, A, Cantón, R, Carmona, P, Carratalà, J, Cordero, E, Cruzado, JM, Fariñas, MC, Fernández-Ruiz, M, Fondevila, C, Fortún, J, García-Cosío, MD, Gutiérrez-Dalmau, A, Iturbe, D, Justo, I, Len, O, López-Medrano, F, Oliva, MOL, Martín-Dávila, P, Martínez-Martínez, L, Mazuecos, A, Mirabet, S, Muñoz, P, Oliver, A, Pérez-Sáez, MJ, Rodríguez-Gómez, J, San-Juan, R, Sánchez-Céspedes, J, Solé, A, Verdú, EV, Villa, J, Torre-Cisneros, J, Aguado, JM. Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.. Transplantation Reviews. 2025; 39(3)DOI:10.1016/j.trre.2025.100937. PMID:40414085. IF:2.500(Q1/1D).

Giralt, M, Ferrer, R, Díaz-Troyano, N, Vega, B, Luque-Ramírez, M, Martínez, S, Fernández, B, Martínez, I, Fabregat, A, Urgell, E, Cardona, I, Casals, G, Escobar-Morreale, HF. Analytical Interference of Exemestane with Androstenedione Immunoassays. Annals of Laboratory Medicine. 2025; 45(4)DOI:10.3343/alm.2024.0362. PMID:40114653. IF:3.900(Q1/1D).

Sardà, H, Genua, I, Miñambres, I. GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease. MEDICINA CLINICA. 2025; 165(1)DOI:10.1016/j.medcli.2025.106951. PMID:40378625. IF:2.100(Q2/3D).

Almendra-Pegueros, R, Barros-Membrilla, AJ, Pérez-Marlasca, E, Julve, J, Martinez-González, J, Rodriguez, C, Galán, M. Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm. Clinica E Investigacion En Arteriosclerosis. 2025; 37(4)DOI:10.1016/j.arteri.2024.09.002. PMID:39424523. IF:(Q/D).

Wyckoff, JA, Lapolla, A, Asias-Dinh, BD, Barbour, LA, Brown, FM, Catalano, PM, Corcoy, R, Di Renzo, GC, Drobycki, N, Kautzky-Willer, A, Murad, MH, Stephenson-Gray, M, Tabák, AG, Weatherup, E, Zera, C, Singh-Ospina, N. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2025; 193(1)DOI:10.1093/ejendo/lvaf116. PMID:40652450. IF:5.200(Q1/2D).

Lazarus, JV, Wajcman, DI, Pannain, S, Brennan, PN, Manolas, MI, Jepsen, P, Treloar, C, Arora, AK, Matthews, PC, Picchio, CA, White, TM, Grebely, J, Vaz, J, Hagström, H, Rabin, KH, Isaacs, S, Ribeiro, RT, Roden, M, Betel, M, Willemse, J, Díaz, LA, Allen, AM, Alkhouri, N, Schattenberg, JM, Mauricio, D, Rinella, ME, Pose, E, Tsochatzis, EA, Ninburg, M, Cusi, K, Alazawi, W, Duseja, A, Frühbeck, G, Lofton, H, Jaisinghani, P, Kanwal, F, Shiha, G, Zelber-Sagi, S, Holden, L, Villota-Rivas, M. The People-First Liver Charter. NATURE MEDICINE. 2025; 31(7)DOI:10.1038/s41591-025-03759-8. PMID:40473951. IF:50.000(Q1/1D).

Araujo-Castro, M, Biagetti, B, Menéndez, E, Novoa-Testa, I, Cordido, F, Berrocal, VR, Pascual-Corrales, E, Guerrero-Pérez, F, Vicente, A, García-Centeno, R, Gonzalez, L, Garcia, MDO, Echarri, AI, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar-Taibo, R, Bernabéu, I, Alvarez-Escola, C, Jimenez, CT, Abellan-Galiana, P, Venegas, E, González-Molero, I, Iglesias, P, Blanco, C, De Lara, FVO, Novoa, MPD, Torres, ELM, Hanzu, F, Lamas, C, Rodriguez, SA, Aulinas, A, Recio, JM, Aviles-Pérez, MD, Núñez, MAS, Camara, R, Fano, MP, Fajardo, C, Cardoso, L, Marques, P, Martínez-Sàez, E, Ruz-Caracuel, I, Marazuela, M, Puig-Domingo, M. Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas. Endocrine Connections. 2025; 14(7)DOI:10.1530/EC-25-0103. PMID:40590355. IF:2.800(Q3/6D).

Villamarín , M, Fernández-Hidalgo, N, Escolà-Vergé, L. Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre-a counterpoint. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2025; 80(7)DOI:10.1093/jac/dkaf164. PMID:40396694. IF:3.600(Q2/3D).

Mosnaim, GS, Price, D, Côté, A, Plaza, V, Xia, CM, Awad, H, Kwah, J. DUPILUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE AND ASTHMA CONTROL IN PATIENTS WITH AND WITHOUT COEXISTING TYPE 2 CONDITIONS: RESULTS FROM THE RAPID STUDY. VALUE IN HEALTH. 2025; 28(6)DOI:. PMID:. IF:6.000(Q1/1D).

Ryan, P, Blanco, JL, Masia, M, Garcia-Fraile, L, Crusells, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, X, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Esteban, H, Gil, P, de Miguel, M, Alejos, B, Martínez, E. Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial. Lancet HIV. 2025; 12(7)DOI:10.1016/S2352-3018(25)00105-5. PMID:40489982. IF:13.000(Q1/1D).

Uyar, GC, Mirallas, O, Baskurt, K, Martin-Cullell, B, Yesilbas, E, Recuero-Borau, J, Kaya, S, Garcés, VN, Yücel, SE, Cano, KSV, Gómez-Puerto, D, Gómez, AP, de Torres, CS, Öksüzoglu, ÖBÇ, Serradell, S, Dienstmann, R, Sutcuoglu, O. Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores. Lancet Regional Health-Europe. 2025; 54DOI:10.1016/j.lanepe.2025.101317. PMID:40672056. IF:13.000(Q1/1D).

Cappuzzo, F, Zvirbule, Z, Korbenfeld, E, Kolb-Sielecki, J, Isla, D, Szczesna, A, Sanchez, AYC, Bustillos, A, Liu, XY, Young, F, Tosti, N, Monteiro, MF, Majem, M. Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC (vol 6, 100815, 2025). Jto Clinical And Research Reports. 2025; 6(7)DOI:10.1016/j.jtocrr.2025.100842. PMID:40534993. IF:(Q/D).

Pietrantonio, F, Salvatore, L, Esaki, T, Modest, DP, Lopez-Bravo, DP, Taieb, J, Karamouzis, MV, Ruiz-Garcia, E, Kim, TW, Kuboki, Y, Meriggi, F, Cunningham, D, Yeh, KH, Chan, EMY, Chao, JS, Tran, Q, Cremolini, C, Fakih, M. Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer. JOURNAL OF CLINICAL ONCOLOGY. 2025; 43(19)DOI:10.1200/JCO-24-02026. PMID:40215429. IF:41.900(Q1/1D).

Bergmann, L, Albiges, L, Ahrens, M, Gross-Goupil, M, Boleti, E, Gravis, G, Flechon, A, Grimm, MO, Bedke, J, Barthélémy, P, Castellano, D, Mellado, B, Ivanyi, P, Rottey, S, Flörcken, A, Suarez, C, Maroto, P, Grünwald, V, Oosting, SF, Kopecky, J, Zschäbitz, S, Boegemann, M, Buchler, T, Niegisch, G, Goebell, PJ, Waddell, T, Joly, F, Priou, F, Retz, M, Siemer, S, Zimmermann, U, Deckbar, D, Burkholder, I, Hartmann, A, Haanen, JB. Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial. ANNALS OF ONCOLOGY. 2025; 36(7)DOI:10.1016/j.annonc.2025.03.016. PMID:40180121. IF:65.400(Q1/1D).

Da Silva, IM, Riera, P, Bernal, S, Manrique, ACV, Cullell, BM, Paez, D. Relevance of ABCG2 and SRPK1 genetic variants in irinotecan-induced severe toxicity. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.05.046. PMID:. IF:65.400(Q1/1D).

Beltran, JS, Serda, PC, Cardozo, AR, Pérez, MAM, Manrique, ACV, Paez, D, Cullell, BM. A retrospective single-center analysis of treatment strategies and real-world outcomes in locally advanced pancreatic cancer. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.05.288. PMID:. IF:65.400(Q1/1D).

Ponce, CG, Méndez, AM, Plazas, JG, Benavente, MDL, Serda, PC, Vazquez, EB, Conesa, MADLAV, Gil, RHS, Gomez, VL, Alfonso, AL, Custodio-Cabello, S, Paladines, WGP, Carmena, MD, Mercade, TM, Tabares, MLS, Martínez, IP, Gutierrez, LC, Martin, AJM, Fonseca, PJ, Pacheco-Barcia, VE. Prognostic significance of the systemic inflammation response index (SIRI) and nutritional status in metastatic pancreatic cancer: Results from the PANTHEIA-SEOM study. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.05.304. PMID:. IF:65.400(Q1/1D).

Pacheco-Barcia, VE, Méndez, AM, Plazas, JG, Rus, ND, Benavente, MDL, Cullell, BM, Gomez, VL, Vazquez, EB, Conesa, MADLAV, Fernandez, SP, Alfonso, AL, Castet, F, Adeva, JA, Fabregat, C, Abad, DG, Contreras, PZ, Carmona-Bayonas, A, Fonseca, PJ, Gutierrez, LC, Martin, AJM. Impact of the systemic inflammation index (SIRI) and artificial intelligence(AI)-based muscle mass (FocusedON® software) on chemotherapy toxicity and prognosis in metastatic pancreatic cancer: A proof-of-concept from the PANTHEIA-Spanish Society of Medical Oncology (SEOM) study group. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.05.305. PMID:. IF:65.400(Q1/1D).

Rubio, MA, Cisa-Wieczorek, S, Mozos, A, Castellet, H, Bussaglia, E, Carricondo, M, Hernández-Alvarez, MI, Sierra, J, Nomdedéu, JF. SGK1 repression by WT1 may confer a survival advantage to leukemic cells under stress conditions. ANNALS OF HEMATOLOGY. 2025; 104(7)DOI:10.1007/s00277-025-06458-z. PMID:40613901. IF:2.400(Q2/5D).

Moreno, DF, Oriol, A, de la Rubia, J, Hernández, MT, Iñigo, MB, Palomera, L, de Arriba, F, González, Y, Teruel, AI, Pardo, JL, de la Guía, AL, Sampol, A, Ríos-Tamayo, R, Sureda, A, Gutiérrez, NC, Calasanz, MJ, Ramos, MLM, Mateos, MV, San Miguel, J, Lahuerta, JJ, Bladé, J, Rosiñol, L. Is t(11;14) Always aStandard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Trials. Clinical Lymphoma Myeloma & Leukemia. 2025; 25(7)DOI:10.1016/j.clml.2025.01.014. PMID:39955256. IF:2.700(Q2/4D).

Giménez, S, Vaqué-Alcázar, L, Zhu, NL, Benejam, B, Arranz, J, Maure-Blesa, L, Videla, L, Carmona-Iragui, M, Barroeta, I, Rebillat, AS, Rodriguez-Baz, I, Bejanin, A, Arriola-Infante, JE, Bueno, A, Fernandez, S, Ribas, L, Zsadanyi, SE, Morcillo-Nieto, AO, Alcolea, D, Lisgaras, CP, Blessing, E, Osorio, RS, Lleo, A, Fortea, J. Impact of Alzheimer's disease on sleep in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(7)DOI:10.1002/alz.70400. PMID:40604343. IF:11.100(Q1/1D).

Betancor, D, Olaguibel, JM, del Pozo, V, Puebla, MJA, Arismendi, E, Barroso, B, Bobolea, I, Cardaba, B, Cañas, JA, Domínguez-Ortega, J, Cruz, MJ, Curto, E, Garcia de la Fuente, A, González-Barcala, FJ, Luna-Porta, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Picado, C, Plaza, V, Quirce, S, Rial, MJ, Soto-Retes, L, Valverde-Monge, M, Mahíllo-Fernández, I, Sastre, J. FEV1Q as a Predictive Metric for Asthma Outcomes. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(7)DOI:10.1016/j.arbres.2025.02.011. PMID:40087119. IF:9.200(Q1/1D).

Almonacid C, Blanco M, Ferreira J, García G, Morete A, Quirce S, Soto-Campos G, Plaza V. Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).. Open Respiratory Archives. 2025; 7(3)DOI:10.1016/j.opresp.2025.100453. PMID:40677934. IF:(Q/D).

Falgas, N, Maure-Blesa, L, Ances, B, Flores-Aguilar, L, Hartley, S, Hassenstab, J, Iulita, MF, Janicki, M, Koenig, K, Lao, PT, Levin, J, McDade, E, Meijer, L, Rafii, MS, Snyder, HM, Sanchez-Valle, R, Fortea, J, Infante, JA, Balasa, M, Barroeta, I, Barthelemy, RN, Bejanin, A, Benejam, B, Bosch, B, Bradshaw, A, Carmona-Iragui, M, Cohen, A, Alberti, AC, Csincsik, L, Cuello, AC, Soriano, LD, Dijkstra, J, Edwards, N, Gimenez, S, Gonzalez-Ortiz, F, Gordon, B, Fernandez, SG, Handen, B, Jacob, C, Johnson, E, Johansson, C, Llado, A, Lleo, A, Morabito, S, Morcillo-Nieto, AO, Montoliu-Gaya, L, Okafor, M, Perez-Millan, A, Potier, MC, Ringman, J, Rodriguez-Baz, I, Rubenstein, E, Ryan, NS, Strydom, A, Vaque-Alcazar, L, Vermunt, L, Toro, LV, Zaman, S. Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference. ALZHEIMERS & DEMENTIA. 2025; 21(7)DOI:10.1002/alz.70309. PMID:40604347. IF:11.100(Q1/1D).

Fernández Alonso, C., Puig Campmany M., Aguiló Mir, S, Rodríguez Miranda, B, López Díez, M.P., Capilla Pueyo, R., Ferré Losa, C, Mir Montero, M, Arnau Barrés, I, Ruíz Grinspan, M, Martín Mojarro, E, Álvarez Rodríguez, E, Sousa Ávila, Y, Piñera Salmerón, P, Liñán López, M, Martín-Sánchez, FJ, Castejón Hernández, S, González-Armengol, JJ, Del Arco Galán, C. Recomendaciones del Grupo de Trabajo sobre Medicina Geriátrica de Urgencias de la Sociedad Española de Medicina de Urgencias y Emergencias sobre el cribado de fragilidad, valoración geriátrica e intervención en el Servicio de Urgencias (Recomendaciones GEM-SEMES). Revista Española de Urgencias y Emergencias. 2025; 4(3)DOI:10.55633/s3me/REUE021.2025. PMID:. IF:(Q/D).

Lisgaras, CP, Giménez, S, Carmona-Iragui, M, Maure-Blesa, L, Blessing, E, Fortea, J, Osorio, RS. High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer's disease dementia. ALZHEIMERS & DEMENTIA. 2025; 21(7)DOI:10.1002/alz.70386. PMID:40642994. IF:11.100(Q1/1D).

Asmarats, L, Arzamendi, D. Fast-track TAVI: establishing a new standard of care. REC, interventional cardiology. 2025; 7(3)DOI:10.24875/RECICE.M25000513. PMID:. IF:(Q/D).

Perea, V, Quirós, C, Herrera-Arranz, MT, Azriel-Mira, S, Wägner, AM, Beato-Vibora, P, Soldevila, B, Barquiel, B, Pardo, RM, Díaz-Soto, G, Picón, MJ, Colomo, N, Amigó, J, Climent, E, Durán-Martínez, M, Corcoy, R, Codina, M, Cuesta, M, Guedes, BV, Vinagre, I. Pregnancy outcomes with the pregestational use of Minimed 780G compared to Minimed 640G: findings from a multicenter cohort study. ACTA DIABETOLOGICA. 2025; 62(7)DOI:10.1007/s00592-024-02430-x. PMID:39630235. IF:2.900(Q3/6D).

Amaro, S, Cruz-González, I, Estévez-Loureiro, R, Millan, X, Nombela-Franco, L, Gómez-Hospital, J, Flores-Umanzor, E, López-Mesonero, L, Maciñeira, J, Prats-Sánchez, L, Simal, P, Cardona, P, Teruel, L, Cepas-Guillén, P, Arzamendi, D, Freixa, X. Left atrial appendage occlusion plus oral anticoagulation in stroke patients despite ongoing anticoagulation: rationale and design of the ADD-LAAO clinical trial. REC, interventional cardiology. 2025; 7(3)DOI:10.24875/RECIC.M25000530. PMID:40933018. IF:(Q/D).

Scilipoti, P, Longoni, M, de Angelis, M, Zaurito, P, Slusarczyk, A, Soria, F, Pradere, B, Krajewski, W, D'Andrea, D, Mari, A, Del Giudice, F, Pichler, R, Subiela, JD, Marcq, G, Gallioli, A, Afferi, L, Mastroianni, R, Simone, G, Albisinni, S, Mertens, LS, Laukhtina, E, Oberneder, K, Elena, JLR, Aranda, J, Puentedura, AL, Velasco, JC, Contieri, R, Hurle, R, Mori, K, Radziszewski, P, Shariat, SF, Gontero, P, Necchi, A, Rouprêt, M, Montorsi, F, Salonia, A, Briganti, A, Moschini, M. Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancer. BJU INTERNATIONAL. 2025; 136(1)DOI:10.1111/bju.16675. PMID:39967051. IF:4.400(Q1/2D).